Gene223
ALDH9A1: aldehyde dehydrogenase 9 family member A1
Cite this record
ConductScience Library. ALDH9A1: aldehyde dehydrogenase 9 family member A1. Genes, record 223. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/223
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P49189 | 4-trimethylaminobutyraldehyde dehydrogenase | 494 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents19
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260139247 A1 | 2026-05-21 | 5448 | P49189 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5448 | P49189 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5448 | P49189 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5448 | P49189 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 20215 | P49189 | Espacenet |
| US 20240067958 A1 | 2024-02-29 | 5448 | P49189 | Espacenet |
| WO 2020043864 A1 | 2020-03-05 | 118 | P49189 | Espacenet |
| US 20190120860 A1 | 2019-04-25 | 87 | P49189 | Espacenet |
| US 20140106981 A1 | 2014-04-17 | 4143 | P49189 | Espacenet |
| US 8586006 B2 | 2013-11-19 | 4143 | P49189 | Espacenet |
NIH grants329
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ALDH9A1 papers | Newest fiscal year |
|---|---|---|---|
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 4 | 2025 |
| R01AA011147 | Ethanol and aldehyde dehydrogenases in health and disease | 3 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 2 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 2 | 2025 |
| P30EY014104 | P30 Core Grant for Vision Research | 2 | 2025 |
| R01EY022305 | NEIGHBORHOOD Consortium for POAG Genetics | 2 | 2025 |
| R01GM065546 | Substrate Channeling and Communication in Proline Metabolic Enzymes | 2 | 2025 |
| R01HD081299 | Ontogeny of drug transport | 2 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 1 | 2025 |
| P01AI120943 | Molecular Mechanisms of Filoviral-host Interactions | 1 | 2025 |
Source NIH's project files
Papers478
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesis and fatty acid oxidation in colorectal cancer. | bioRxiv | 2026 | 42818236 | PubTator, text mining | PubMed |
| Machine Learning-Guided Multi-Omics Integration Identifies UGCG as a Candidate Lipid Metabolic Biomarker and Potential Therapeutic Target in Sepsis. | J Inflamm Res | 2026 | 42808034 | PubTator, text mining | PubMed |
| Single-cell multiomics identifies an ALDH9A1-carnitine signaling axis driving resistance of NSCLC to immunotherapy. | Proc Natl Acad Sci U S A | 2026 | 42574617 | PubTator, text mining | PubMed |
| Stratification by a polygenic risk score of common variation aids in Alzheimer's disease rare variant discovery. | Alzheimers Dement | 2026 | 42557982 | PubTator, text mining | PubMed |
| Comprehensive computer analysis of an intratumoral viable biological agent as a systemic multi-mechanistic therapeutic strategy for pancreatic cancer treatment. | In Silico Pharmacol | 2026 | 42383223 | PubTator, text mining | PubMed |
Differential DNA methylation in blood as potential mediator of the association between ambient PM2.5 and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort. | Mol Psychiatry | 2026 | 42270761 | PubTator, text mining | PubMed |
| Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study. | Br J Cancer | 2026 | 41965938 | PubTator, text mining | PubMed |
| BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppression. | Neoplasia | 2026 | 41875824 | PubTator, text mining | PubMed |
| Unbiased Discovery of Genetic Determinants of Resilience to CAD: Insights From PROMISE and CATHGEN. | JACC Adv | 2026 | 41855749 | PubTator, text mining | PubMed |
| A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease. | Acta Neuropathol | 2026 | 41851356 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/223
GET https://conductscience.org/api/genes/v1/223/patents